New drug trial aims to slow kidney damage in IgA nephropathy
NCT ID NCT06454110
First seen Apr 21, 2026 · Last updated Apr 21, 2026
Summary
This study is testing whether an experimental drug called NM8074 can reduce protein loss in urine for people with IgA nephropathy, a kidney disease. Researchers will give the drug to 10 adult patients for 99 days and measure changes in their urine protein levels and kidney function. The goal is to see if NM8074 can help control disease progression and protect kidney health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IGA NEPHROPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.